, tumour necrosis factor α (TNFα), and interleukin-1β are important clinical prognostic markers in ICU septic patients. The goal of the study was to determine whether continuous venovenous haemofiltration (CVVH), using an AN69 haemofilter, leads to elimination of PCT, TNFα, IL-6 and IL-1β in 13 septic patients with multi-organ failure.
Sepsis is an increasingly common cause of morbidity and mortality in the intensive care unit (ICU). Sepsis is a systemic inflammatory response syndrome (SIRS) that has a suspected or proven microbial infectious aetiology 1 . Procalcitonin (PCT) and the proinflammatory cytokines interleukin-6 (IL-6), tumour necrosis factor a (TNFα) and interleukin-1β (IL-1β) are important clinical prognostic markers in septic patients. IL-6, TNFα and IL-1β are sepsis mediators released from macrophages and other inflammatory cells as a result of contact with microbial endotoxins or other microbial components, thus activating several inflammatory cascades. Although this is a beneficial effect, if the insult is not contained the exaggerated activation of the inflammatory response may result in excessive systemic concentrations, leading to diffuse injury of healthy tissues, multiple organ dysfunction 2 .
Nylen et al 3 presented the first evidence that PCT, one of the best markers of sepsis 4 , may actually be a sepsis mediator and could have an integral role in the inflammatory process.
Therapies aimed at blocking specific single mediators of the inflammatory response, such as IL-1 receptor antagonists 5 , or monoclonal anti-TNFα 6 , have failed to demonstrate an improvement in outcome of patients with sepsis. These therapies can only reduce the systemic concentrations of a single mediator but not effectively attenuate the entire response when a broader reduction is necessary. Thus the non-specific simultaneous removal of over-abundant systemic mediators with different molecular sizes via continuous venovenous haemofiltration (CVVH) might be beneficial in re-establishing control of the inflammatory response.
The aim of our study was to determine whether CVVH, using an AN69 haemofilter (PRISMA™, Hospal, France), leads to elimination of PCT, TNFα, IL-6 or IL-1β in septic patients with multi-organ failure.
PATIENTS AND METHODS
A priori power calculation showed that 13 patients would be required to reveal a statistically significant plasma cytokine concentration reduction during CVVH. After approval of our local ethics committee, written informed consent was obtained from all patients who agreed to participate in the study. Patients who were on corticosteroids or immunosuppression therapy that might influence the immune response, were excluded from the study. Thirteen consecutive patients diagnosed on admission to the ICU with SIRS/sepsis according to the ACCP/SCCM consensus conference 1 , and multiple organ failure 7 , were included in the study. All patients were treated with antibiotics as indicated by microbiological resistance testing.
Vascular access was obtained by insertion of a double-lumen haemofiltration venous catheter in the subclavian or jugular vein. CVVH at a blood flow of 100 to 150 ml/min and a filtration rate of 2 l/h was performed using an AN69 (copolymer of acrylonitrile and sodium methallyl sulfonate) hollow fiber haemofilter (PRISMA™) with an effective surface area of 0.9 m 2 . The ultrafiltrate was quantitatively replaced from a 4500 ml bag (HaemoFL 03, Leopold, Austria) by a 37°C isotonic balanced electrolyte solution to maintain a zero fluid balance. Systemic heparin was adjusted by hourly measurements to maintain an activated clotting time of 140 to 160 s.
Blood samples were collected from the afferent port, efferent port, ultrafiltrate port and from the urethral catheter at the start of haemofiltration (0), 6 and 12 hours of therapy. Samples were collected in two ethylenediaminetetracetic acid (EDTA) tubes, and then chilled on ice. Samples were doubly analysed and the average of the two samples represented the mediators' concentration. Plasma was isolated by 3500 rpm centrifugation at 4°C for 10 minutes. Samples were subsequently stored at -70°C. Quantitative sandwich enzyme immunoassay (QuantiGlo™, R&D Systems Inc., MN) was used for cytokine assay. The minimum detectable IL-6, TNFα, and IL-1β concentrations were typically less than 0.2, 0.1, 0.02 pg/ml respectively. PCT was assayed using immunoluminometric technique (LUMItest®, B.R.A.H.M.S. diagnostica, Berlin). The minimum detectable PCT concentration was typically less than 0.3 ng/ml.
Calculations
The following formulae, according to De Vriese et al 8 
Statistical analysis
Analysis of variance (ANOVA) was used for parametric data analysis. Repeated measures ANOVA was used for the analysis of the main effect (afferent/ efferent difference)-time interaction. Data was expressed as mean ±SD. P<0.05 was considered statistically significant.
RESULTS
Patient's demographics, origin of SIRS/sepsis, organ system failure score 7 , at ICU admission as well as their survival outcome, are presented in Table 1 .
The efferent plasma concentrations of PCT, IL-6 and TNFα were significantly lower than the corresponding afferent concentrations. Plasma concentrations significantly declined over time. PCT, IL-6 and TNFα were detected in the ultrafiltrate of all patients. IL-1β was only detectable in the plasma of 8 patients and the ultrafiltrate of 5 patients (Figures 1  and 2 ).
Sieving coefficient of PCT was significantly higher than that of IL-6, TNFα and IL-1β. The highest plasma clearance of PCT, IL-6 and TNFα was at 6 h. There was no significant change in filtrate clearance of PCT or the cytokines over time ( Table 2) .
DISCUSSION

PCT and cytokines plasma concentrations
The results of our study demonstrated that CVVH using an AN69 membrane was associated with a significant decline in PCT, IL-6 and TNFα plasma concentrations. Some of our study patients, assumed to be in the initial cytokine generating phase, could have been approaching the time of the counter inflamma- Cytokines and PCT elimination via CVVH in septic patients was disputed in a number of previous studies using different CVVH membranes [9] [10] [11] [12] [13] [14] . PCT plasma levels were not significantly altered during CVVH with a polysulphone (PS) membrane 9 . The plasma concentrations of IL-6 and TNFα remained unchanged during CVVH with a polyacrylonitrile (PAN) membrane 10 . A second PAN membrane study demonstrated that CVVH was associated with a decrease in plasma TNFα concentration but not that of IL-6 11 . No significant reduction of IL-6, TNFα, or IL-1β plasma concentrations was reported using a PS 12 or polyamide membranes 13, 14 . Contrary to our results, failure of the above mentioned studies to demonstrate a significant reduction in mediator levels are mainly due to the smaller pore size and different surface composition of their synthetic haemofiltration membranes, yielding a much lower convective and adsorptive clearance of PCT and proinflammatory cytokines than the AN69 8, 15 .
Sieving coefficient describes the passage of a molecule through a membrane, and an absolute value of 1.0 would indicate complete filtration of the mediator 8 . Our results showed that the sieving coefficient of PCT, with the lowest MW (13 KD), was approximately twice that of the bigger MW cytokines T TN NF Fα α p pl la as sm ma a a an nd d u ul lt tr ra af fi il lt tr ra at te e c co on nc ce en nt tr ra at ti io on ns s T TN NF Fα α ( (p pg g/ /m ml l) ) n n= =1 13 3 I IL L--1 1β β ( (p pg g/ /m ml l) ) p pl la as sm ma a c co on nc ce en nt tr ra at ti io on n ( (n n= =8 8) ) u ul lt tr ra af fi il lt tr ra at te e c co on nc ce en nt tr ra at ti io on n ( (n n= =5 5) ) (17-26.2 KD), indicating more efficient filtration of PCT than the other three cytokines.
PCT and cytokine clearance
Our results demonstrated a wide difference between the plasma clearance, defined as the volume of plasma cleared of a mediator per minute, and the corresponding ultrafiltrate clearance. This difference represents mediator removal by membrane adsorption and urinary excretion. In our study patients, renal failure and anuria or oligouria rendered obtaining urine samples at the study time points difficult. Urine samples were obtained from five patients, in which the mediators were not detectable. This is in accordance with a recent study indicating that renal elimination of PCT is not a major mechanism for its plasma removal 16 . Similarly, urinary cytokine clearance accounts to a minor fraction of their total clearance 10 . Thus the mediator elimination which we demonstrated in our study is mainly attributable to membrane adsorption. The high adsorptive properties of the AN69 membrane result from its hydrogel consistency, high hydrophilicity and dense symmetrical structure. This favours contact of blood over all its polymeric chains, thus making a large surface area of pores available for adsorption 8 .
In our study, the decline in mediator plasma clearance and sieving coefficient after 12 hours indicates a reduction in adsorptive elimination as a result of progressive membrane saturation with longer blood-membrane contact. Thus after 12 hours, in order to restore high plasma mediator clearance, a new haemofilter membrane should be installed.
Survival outcome
The survival rate among our patients was 62%. However since our study was not intended as a randomized controlled outcome study, our design and the number of patients recruited did not allow us to fully examine the effect of CVVH on the survival outcome of septic patients. The value of CVVH as a mode of therapy affecting the survival outcome of septic patients was disputed, based mainly upon the previously mentioned reports of low efficiency of mediator removal 17 . PCT levels closely correlated, with a high discriminative power, to severity as well as survival outcome of septic patients 18, 19 . Since our study showed that CVVH with AN69 membrane efficiently removes PCT and proinflammatory cytokines, this could have a beneficial positive impact on patient outcome.
In conclusion, we demonstrated that if PCT, IL-6
and TNFα are used as clinical prognostic markers in septic patients who are treated with CVVH using an AN69 membrane, one should be aware that their plasma level could be modified by the therapy. In addition, CVVH could represent an appropriate tool to remove a broad spectrum of proinflammatory mediators, if such removal is required in septic patients.
